Australia markets close in 5 hours 23 minutes
  • ALL ORDS

    7,098.90
    -8.20 (-0.12%)
     
  • ASX 200

    6,814.40
    -9.30 (-0.14%)
     
  • AUD/USD

    0.7767
    +0.0017 (+0.23%)
     
  • OIL

    53.05
    -0.08 (-0.15%)
     
  • GOLD

    1,870.20
    +4.30 (+0.23%)
     
  • BTC-AUD

    40,215.47
    -4,857.31 (-10.78%)
     
  • CMC Crypto 200

    608.80
    -71.11 (-10.46%)
     
  • AUD/EUR

    0.6381
    -0.0014 (-0.23%)
     
  • AUD/NZD

    1.0753
    -0.0046 (-0.42%)
     
  • NZX 50

    13,336.86
    +224.66 (+1.71%)
     
  • NASDAQ

    13,404.99
    +108.54 (+0.82%)
     
  • FTSE

    6,715.42
    -24.97 (-0.37%)
     
  • Dow Jones

    31,176.01
    -12.39 (-0.04%)
     
  • DAX

    13,906.67
    -14.73 (-0.11%)
     
  • Hang Seng

    29,927.76
    -34.74 (-0.12%)
     
  • NIKKEI 225

    28,756.86
    +233.56 (+0.82%)
     

A Biopharmaceutical Contract Manufacturing Significantly Improves Supply Chain Efficiency and Signs a Major Deal | Infiniti’s Recent Success with Market Monitoring Solutions

·3-min read

A reduction in the overall investment required to bring a new product into the market is compelling pharmaceutical companies to outsource to contract manufacturing organizations to meet their needs and reduce risks. However, factors such as the rising demand for affordability, the complexities of supply chain operations, quality compliance, and regulatory scrutiny are hindering growth in the biopharmaceutical contract manufacturing market. Infiniti’s market monitoring solutions enable biopharmaceutical contract manufacturing companies to monitor market uncertainties and develop strategies to tackle upcoming challenges.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201203005764/en/

To leverage Infiniti’s market monitoring solutions, prepare for market uncertainties, and keep abreast of major changes in the biopharmaceutical contract manufacturing market, request a free proposal.

"Market research experts at Infiniti predict that factors such as the rising demand for affordability, the complexity of supply chain operations, quality compliance, and regulatory scrutiny could hinder the market growth of the global biopharmaceutical contract manufacturing industry," says a biopharmaceutical manufacturing market expert at Infiniti Research.

Business Challenge:

A client is a biopharmaceutical contract manufacturing firm based out of the United States. They faced challenges with ensuring affordability, quality, and delivery performance while maintaining competitiveness. Additionally, increasing challenges such as complex supply chain operations, quality compliance, and changing regulatory requirements affected the client’s business. To achieve this, the client chose to leverage Infiniti’s expertise in offering market monitoring solutions. During the eight-week engagement, the client also sought to address difficulties in meeting price expectations, resolve supply chain complexities, and understand the biopharmaceutical contract manufacturing market's technological breakthrough.

Our Approach:

To assist the biopharmaceutical contract manufacturing firm, Infiniti’s market monitoring experts developed a comprehensive approach that included the following:

  • Creating a framework with key questions and hypotheses specific to the US biopharmaceutical contract manufacturing and an extensive database through secondary research

  • Identifying top industry players and analyzing factors such as revenue, market share, and clients in comparison to the client, and generated insights after validating the data with a market monitoring engagement

  • Conducting a technology assessment study to identify technological breakthroughs in the industry and providing detailed insights about the cost of implementation

  • A demand management study to understand supply chain challenges and recommending cold chain packaging technologies to maintain quality standards

Business Outcome:

By leveraging Infiniti’s market monitoring solution, the biopharmaceutical contract manufacturing client reduced operating costs by adopting lean practices and improving process technology. The engagement also enabled the client to identify highly specialized engineering equipment and processes to prevent cross-contamination and enhance operational efficiency. The biopharmaceutical contract manufacturing firm was also able to cope with a wider range of new temperature requirements due to its focus on cold shipping and cold packaging solutions. Additionally, the contract manufacturer` reduced complexities associated with supply chains by understanding and undertaking major industry players’ supply chain strategies.

By leveraging Infiniti’s clinical landscape study, the client was also able to:

  • Acquire a strong, competitive network with suppliers, manufacturing plants, and distributors, and consequently save huge operational costs

  • Improve efficiency in the supply chain to manage better inventory, distribution logic, and the complexities of the cold chain

  • Sign a $2 million deal with a leading pharmaceutical company in the US

Speak to industry experts to gain a more comprehensive understanding of how our market monitoring solutions help biopharmaceutical contract manufacturing firms gain a strategic edge and stay ahead of their competitors in this challenging market.

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to analyze competitive activity, see beyond market disruptions and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us

View source version on businesswire.com: https://www.businesswire.com/news/home/20201203005764/en/

Contacts

Infiniti Research
Anirban Choudhury
Marketing Manager
US: +1 844 778 0600
UK: +44 203 893 3400
https://www.infinitiresearch.com/contact-us